Promediq'a Sp. z oo has been successfully operating on the Polish market for many years. The company's activity focuses on the development and sale of modern, top-quality products. Based on its experience in the field of pharmacy and proficiency in cosmetology, Promediq has created brands offering innovative lines of dietary supplements and exclusive biocosmetics for its clients.
As a company, we also specialize in contract manufacturing of dietary supplements and cosmetics. Depending on your needs, we not only produce, but also support our clients in finding optimal product solutions, we provide them with full advice regarding the selection of raw materials, preparation and production, and confection. Both the production volume and the dates of its production are each time adapted to the customer's requirements.
Customer loyalty is for us the basic measure of success and is the most important determinant confirming the quality of our services and the effectiveness of products. Customer satisfaction is the strongest motivation for the team of employees of the company to constantly improve the offer.
47.73.Z - Retail sale of pharmaceutical products
20.42.Z - Manufacture of cosmetics and toilet preparations
46.38.Z - Wholesale trade of other food products
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
46.76.Z - Wholesale trade
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,6 | -0 | -101,6 | |
Gross profit (loss) | 0,4 | 3,2 | -0,1 | -101,9 |
EBITDA | 0,5 | 2,6 | -0 | -101,7 |
Short time liabilities | 1,4 | 107,4 | 107,5 | 0 |
Other operating costs | 0,4 | 0 | -95,6 | |
Equity capital | 0,6 | 3,2 | 3,1 | -1,4 |
Operating profit (EBIT) | 0,4 | 2,5 | -0,1 | -102,4 |
Assets | 2,2 | 110,8 | 110,8 | 0 |
Net profit (loss) | 0,3 | 2,6 | -0,1 | -102,4 |
Cash | 0,1 | 0 | 0 | -73,8 |
Liabilities and provisions for liabilities | 1,6 | 107,7 | 107,7 | 0 |
Net income from sale | 1,9 | 89,1 | 0 | -100 |
Working assets | 1,6 | 110,6 | 110,6 | 0 |
Other income costs | 0,3 | 0 | -100 | |
Depreciation | 0,1 | 0 | 0 | -67,1 |
% | % | % | p.p. | |
Profitability of capital | 48,5 | 80,9 | -1,9 | -82,8 |
Equity capital to total assets | 26,9 | 2,8 | 2,8 | 0 |
Gross profit margin | 18,8 | 3,6 | -556,9 | -560,5 |
EBITDA Margin | 25,4 | 2,9 | -407,9 | -410,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 270 | 440 | 3 620 219 | 3 619 779 |
Current financial liquidity indicator | 1.0297539234161377 | 1.029494285583496 | 0 | |
Net dept to EBITDA | 0.12178193032741547 | -7.6598381996154785 | -7,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane